Altaviz is the global leader in designing gas-powered delivery systems. Learn how to harness gas-power for delivery of High Viscosity / High-Volume biologics and challenging drug delivery applications with the AltaVISC High Viscosity / High-Volume Auto-Injector; one of a portfolio of Altaviz gas-powered drug / implant delivery technologies. To learn more, please visit www.altaviz.com

Piezo Therapeutics aims to transform the delivery of nucleic acid medicines to enable improved safety, efficacy, affordability, and scalability. Piezo is developing a uniquely engineered platform that uses electric pulses and microneedles to deliver a broad range of therapeutics inside the body and is simple, cost-effective, and rapid to produce at scale. To learn more please visit: www.piezotx.com

Portal is transforming medicine by allowing chronic patients to self-inject their biological drugs with a needle-free device. This innovative drug delivery system replaces auto-injectors and is overwhelmingly patient preferred. Issued from MIT Research and easily connected to the cloud, the Portal device allows biopharmaceutical companies to augment their biological therapies and differentiate them from competitors. The device captures injection data in real time and transmits those via the cloud to all stakeholders for optimal care. Portal’s business model is to partner with biopharmaceutical companies and co-develop drug/device combination products. The company has partnerships with Takeda Pharmaceuticals, Sanofi SA and 3M. To learn more, visit www.portalinstruments.com

H&T Presspart is a world leader and specialist in the design, development and manufacture of drug delivery devices and pharmaceutical components. With 50 years’ experience in partnering with the world’s leading pharma companies we have developed a strong reputation for precision and reliability – critically important when patients’ quality of life depends on our products. To learn more visit www.presspart.com

ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. ReCode’s SORT LNPs are engineered with a biochemically distinct fifth lipid to help the body “sort” and direct the LNPs to other targeted organs such as the lung and spleen with the ability to bypass the liver, if desired. For more information, visit www.recodetx.com and follow us on Twitter @ReCodeTx and LinkedIn.

Renishaw Neuro Solutions enables direct-to-target delivery for a broad range of applications. Using the neuroinfuse™ drug delivery system, predictable and translatable therapy infusions in R&D and clinical trials can become a reality. Our Lab2Clinic™ service supports pharma through the R&D journey, translating into clinical trials and scaled-up commercialisation. To learn more, visit https://.renishaw.com

Rx Bandz is redefining auto-injectors with MiniJect® – the world’s smallest rugged, waterproof, temperature-resistant, with easy-to-use features for injection in two simple steps. MiniJect’s versatility as a drug delivery platform allows for the reliable delivery of a wide range of injectable medications, including highly viscous biologics from 1mL to 5mL. Transform your patient’s drug delivery experience with MiniJect. To learn more please visit: www.rxbandz.com

Sanofi is an innovative global healthcare company, driven by one purpose: chasing the miracles of science to improve people’s lives. We transform the practice of medicine, turning the impossible into the possible for patients. We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people. For more information please visit www.sanofi.com

Scherdel Medtech is a family owned, leading global, metal component solutions provider for the medical device and drug delivery markets. We don’t just provide solutions, we provide care. To learn more, visit https://www.scherdel.com/?lang=en

Secant Group, a global biomaterials leader, offers an innovative controlled active release technology platform Hydralese™, a bioresorbable polymer that enables sustained drug delivery via surface erosion. Specializing in formulation and development services for a variety of API’s and finished dosage forms including implantable rods and microspheres, we have the expertise to support pharmaceutical customers seeking to improve patient compliance and healthcare globally. Learn more at www.secant.com/hydralese

SeraNovo, a Netherlands-based oral formulation company, specializes in enhancing the bioavailability of water-insoluble small molecules. Leveraging our proprietary eutectic formulation platforms and efficient one-step manufacturing process, we significantly reduce drug development timelines and expedite access to the clinic. To learn more, please visit www.seranovo.com

SHL Medical is a world-leading solutions provider in the design, development, and manufacturing of advanced delivery devices such as autoinjectors, pen injectors, and wearable drug delivery systems. We offer final assembly, labeling, and packaging solutions for our drug delivery devices, and also provide contract manufacturing and engineering services for the production of complex medtech and industrial products. With locations in Switzerland, Taiwan, Sweden, and the US, our experienced designers and engineers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investments in R&D have enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high-volume and high-viscosity formulations and can be enhanced through digital implementations. To learn more, visit www.shl-medical.com